Skip to main content

Peer Review reports

From: QSAR and molecular docking studies of isatin and indole derivatives as SARS 3CLpro inhibitors

Original Submission
23 Nov 2022 Submitted Original manuscript
5 Dec 2022 Reviewed Reviewer Report
4 Mar 2023 Author responded Author comments - Shahin Ahmadi
Resubmission - Version 2
4 Mar 2023 Submitted Manuscript version 2
6 Mar 2023 Author responded Author comments - Shahin Ahmadi
Resubmission - Version 3
6 Mar 2023 Submitted Manuscript version 3
Publishing
31 Mar 2023 Editorially accepted
7 Apr 2023 Article published 10.1186/s13065-023-00947-w

You can find further information about peer review here.

Back to article page